Nairobi, Jan. 15 -- Kenya stands at a crucial moment in its battle against cervical cancer, banking on a policy shift that health experts believe will fundamentally reshape the fight against a disease claiming over 3,500 women's lives every year, according to the latest Globocan, an interactive web-based platform presenting global cancer statistics.

"Cervical cancer is the second most common cancer among women and a leading cause of cancer deaths. Every day, 10 women in Kenya lose their lives to cervical cancer, and without decisive action, this number could rise to 22 daily deaths by 2040," said Globocan.

The transition to a single-dose HPV vaccination in November 2025 represents a strategic recalibration that could finally make the Wo...